Physician profile
Cortney A Bernardo
NPI 1285735688
$8,209.10
in general payments reported to CMS, 2019-2025
27 companies · $770 in 2025
The $770 reported for 2025 was more than what 75% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,384 · 2022: $742 · 2023: $1,152 · 2024: $1,162 · 2025: $770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,083.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,727.29 | 2021-2025 | Artisan, Coveredge 32, Infinion 16 |
| Biohaven Pharmaceuticals, INC. | $1,023.61 | 2021 | |
| Abbvie INC. | $890.47 | 2022-2025 | |
| Nevro Corp. | $343.75 | 2021-2023 | Senza |
| Medtronic, INC. | $341.85 | 2023-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Pfizer INC. | $325.90 | 2023-2025 | |
| Lundbeck LLC | $156.21 | 2021-2025 | Vyepti |
| Nalu Medical, INC. | $144.90 | 2021-2023 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $142.79 | 2021-2024 | Relistor |
| Abbott Laboratories | $130.54 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $113.17 | 2021-2022 | |
| Relievant Medsystems, INC. | $84.59 | 2021-2023 | Intracept |
| Spr Therapeutics, INC | $83.58 | 2023-2024 | Sprint Pns System |
| Grt US Holding, INC. | $83.56 | 2021-2022 | |
| Averitas Pharma INC. | $83.05 | 2023-2025 | Qutenza |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $76.92 | 2022 | |
| Allergan, INC. | $76.68 | 2021 | |
| Redhill Biopharma INC. | $74.91 | 2021-2023 | Movantik, Talicia, Aemcolo |
| Amgen INC. | $70.25 | 2021-2022 | |
| Vertos Medical, INC. | $59.32 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $34.91 | 2021-2022 | |
| Radius Health, INC. | $33.68 | 2021 | |
| Lilly USA, LLC | $32.47 | 2021 | |
| Bioventus LLC | $23.46 | 2022 | |
| Protega Pharmaceutials INC | $20.23 | 2025 | Roxybond |
| Vertex Pharmaceuticals Incorporated | $16.20 | 2025 | |
| Biodelivery Sciences International, INC. | $14.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cortney Bernardo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.